These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17389696)

  • 1. Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome.
    Luque-Ramírez M; Alvarez-Blasco F; Mendieta-Azcona C; Botella-Carretero JI; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2141-8. PubMed ID: 17389696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess.
    Luque-Ramírez M; Martí D; Fernández-Durán E; Alpañés M; Álvarez-Blasco F; Escobar-Morreale HF
    Hypertension; 2014 Mar; 63(3):624-9. PubMed ID: 24324038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome.
    Zachurzok-Buczynska A; Szydlowski L; Gawlik A; Wilk K; Malecka-Tendera E
    Fertil Steril; 2011 Dec; 96(6):1519-25. PubMed ID: 22032814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
    Mioni R; Cà AD; Turra J; Azzolini S; Xamin N; Bleve L; Maffei P; Vettor R; Fallo F
    Endocrine; 2017 Feb; 55(2):625-634. PubMed ID: 27142411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
    González F; Minium J; Rote NS; Kirwan JP
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance.
    Ketel IJ; Stehouwer CD; Serné EH; Korsen TJ; Hompes PG; Smulders YM; de Jongh RT; Homburg R; Lambalk CB
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3365-72. PubMed ID: 18593766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?
    Holte J; Gennarelli G; Berne C; Bergh T; Lithell H
    Hum Reprod; 1996 Jan; 11(1):23-8. PubMed ID: 8671152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL; Stepto NK; Hutchison SK; Teede HJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):351-7. PubMed ID: 21711376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between 24-hour ambulatory blood pressure measurement and selected biochemical and anthropometric parameters in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Szynkaruk-Matusiak M; Osowska K; Dryś A; Olszanecka-Glinianowicz M; Madej P
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3947-3954. PubMed ID: 34156673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reduced nocturnal systolic blood pressure dip in obese children].
    Ruiz Pons M; García Nieto V; García MG; García Mérida M; Valenzuela Hdez C; Aguirre-Jaime A
    Nefrologia; 2008; 28(5):517-24. PubMed ID: 18816210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M; Naka KK; Kalantaridou SN; Kazakos N; Katsouras CS; Makrigiannakis A; Paraskevaidis EA; Chrousos GP; Tsatsoulis A; Michalis LK
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in sexual function among women with polycystic ovary syndrome: a pilot study.
    Ferraresi SR; Lara LA; Reis RM; Rosa e Silva AC
    J Sex Med; 2013 Feb; 10(2):467-73. PubMed ID: 23210985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile.
    Barcellos CR; Lage SH; Rocha MP; Hayashida SA; Baracat EC; Romano A; Brito VN; Marcondes JA
    Gynecol Endocrinol; 2013 Apr; 29(4):370-4. PubMed ID: 23327607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.